Tarnate, Renerose .

HRN: 28-15-34  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/24/2025
CEFUROXIME 500MG (TAB)
11/24/2025
12/01/2025
PO
500 Mg
BID
Thickly MSAF S/P NSVD With RMLE
Checking Initial Appropriateness 
11/24/2025
METRONIDAZOLE 500MG (TAB)
11/24/2025
12/01/2025
PO
500 Mg
TID
Thickly MSAF S/P NSVD With RMLE
Checking Initial Appropriateness 
11/27/2025
CEFUROXIME 500MG (TAB)
11/27/2025
12/01/2025
PO
500mg
BID
THICKLY MSAF
Waiting Final Action 
11/27/2025
METRONIDAZOLE 500MG (TAB)
11/27/2025
12/01/2025
PO
500mg
TID
THICKLY MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: